HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiffany Jamison Selected Research

Conjunctivitis

3/2008The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiffany Jamison Research Topics

Disease

2Bacterial Conjunctivitis
02/2010 - 03/2008
1Conjunctivitis
03/2008
1Bacterial Eye Infections
02/2008
1Cataract (Cataracts)
02/2008
1Haemophilus Infections
09/2007

Drug/Important Bio-Agent (IBA)

3Tobramycin (Nebcin)FDA LinkGeneric
02/2010 - 09/2007
2Moxifloxacin (Avelox)FDA Link
02/2010 - 09/2007
2Gentamicins (Gentamicin)FDA LinkGeneric
02/2010 - 09/2007
2Azithromycin (Zithromax)FDA LinkGeneric
03/2008 - 09/2007
1AminoglycosidesIBA
02/2010
1FluoroquinolonesIBA
02/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
02/2008
1Dexamethasone Drug Combination TobramycinFDA LinkGeneric
02/2008
1SuspensionsIBA
02/2008
1Anti-Bacterial Agents (Antibiotics)IBA
09/2007
1Polymyxin B (Aerosporin)FDA LinkGeneric
09/2007
1Trimethoprim (Proloprim)FDA LinkGeneric
09/2007